Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery

被引:0
作者
Keisuke Morimoto
Tohru Mori
Shingo Ishiguro
Naruto Matsuda
Yohichi Hara
Hiroaki Kuroda
机构
[1] Tottori University Faculty of Medicine,Second Department of Surgery
来源
Surgery Today | 1998年 / 28卷
关键词
brain natriuretic peptide; cardiopulmonary bypass; cardiac surgery;
D O I
暂无
中图分类号
学科分类号
摘要
The plasma concentrations of brain natriuretic peptide (BNP), a cardiac hormone, were measured in 30 consecutive adult patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) during the perioperative period. BNP concentrations remained unchanged until 6 h after the cessation of bypass, and were elevated 12, 24, and 48 h post-bypass (P<0.0001 versus baseline). They had returned to the baseline values when measured 3 weeks postoperatively. The preoperative plasma BNP concentration correlated significantly with the left ventricular ejection fraction (r=-0.895). The peak plasma BNP concentration 24 h after bypass correlated with the cardiac index (r=-0.64), stroke volume index (r=-0.62), injection rate of dopamine hydrochloride (r=0.65), and aortic crossclamp time (r=0.57). There was also a significant correlation between the preoperative BNP concentration and the plasma BNP concentration 24 h post-CPB. These findings led us to conclude that the plasma concentrations of BNP become markedly and acutely elevated after cardiac surgery with CPB, and reflect the state of left ventricular function. Moreover, the severity of acute heart failure after cardiac surgery can be predicted by the preoperative plasma BNP concentration.
引用
收藏
页码:23 / 29
页数:6
相关论文
共 201 条
[21]  
Jougasaki M(1988)Atrial natriuretic peptide plasma levels during cardiac surgery J Cardiothorac Anesth 2 274-280
[22]  
Imura H(1991)Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients Eur J Cardiothorac Surg 5 205-210
[23]  
Sudoh T(1989)Influence of hypothermic cardiopulmonary bypass on atrial natriuretic factor levels Can J Anaesth 36 545-553
[24]  
Kangawa K(1987)Heparin interferes with the biological effectiveness of atriopeptin Hypertension 9 607-610
[25]  
Minamino N(1995)Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction Am Heart J 129 139-145
[26]  
Matsuo H(1993)Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure Circulation 87 464-469
[27]  
Ogawa Y(1995)Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy. Changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor Am J Med 98 257-265
[28]  
Nakao K(1994)Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 195-203
[29]  
Mukoyama M(undefined)undefined undefined undefined undefined-undefined
[30]  
Shirakami G(undefined)undefined undefined undefined undefined-undefined